Artemisinin Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Market Dynamics of Artemisinin Market Analysis

↑ Growth Drivers

  • Expanding the range of applications in the pharmaceutical sector.
  • A rise in R&D and expanding medical infrastructure, especially in developing nations like China and India to Drive Market Growth
  • Worldwide malaria infections are on the rise, with endemic areas such as Sub-Saharan Africa seeing the highest need for effective treatments.

↓ Restraints

  • Fluctuations in the availability of Artemisia annua brought on by crop diseases, climate change, and agricultural difficulties will limit market growth
  • The affordability and overall cost of artemisinin-based products are impacted by the extraction and production costs of raw artemisinin, which can be substantial.

~ Trends

  • The favored treatment for malaria is a growing number of combination medicines based on artemisinin.
  • Advancements in agriculture and extraction methods that increase sustainability and efficiency.

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Artemisinin Market Analysis — Presence

Interactive World Map

Click countries to explore
Loading map…

Regional and Country Analysis

  • North America — United States, Canada, Mexico
  • Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
  • Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
  • South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
  • Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
  • Africa — East Africa, West Africa, North Africa, South Africa

Region / Country 2021 (A)2025 (A)2033 (P) CAGR

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis

Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitive Landscape of the Artemisinin Market

In the artemisinin market's competitive landscape, numerous key competitors are driving innovation and growth. Major players, such as research and development, new product development, geographic expansion, and indication expansion, are pursuing a number of different marketing strategies. Global powerhouses produce the majority of medications, and industry leaders have established themselves in the market by increasing their investment in research and developing better distribution networks.

In November 2022, Novartis and Anti-Malaria Drugs Venture announced that it will proceed to Phase 3 research of a novel combination of ganaplacide/lumefantrine-SDF for treating malaria in adults and children. Unlike traditional artemisinin therapies, this regimen is designed to be administered once daily and targets resistant strains of malaria. (Source: https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-announce-decision-move-phase-3-study-novel-ganaplacidelumefantrine-sdf-combination-adults-and-children-malaria) In April 2024, Fosun Pharma unveiled their second-generation injectable artesunate, which has a one-step preparation method, making administration easier and lowering treatment expenses for severe malaria. This novel formulation is especially beneficial in malaria-endemic areas like Africa, where access to medical care is limited. The medication was highlighted at the 2023 Pan-African Malaria Conference when its function in treating severe Plasmodium falciparum malaria was discussed. (Source: https://www.fosunpharma.com/en/content/details37_13124.html) In December 2022, According to the World Malaria Report 2022, the following regions experienced an increase in malaria cases in 2021: Comoros (56.9%), Costa Rica (52.4%), the Democratic People's Republic of Korea (22.8%), Ecuador (11.1%), Eswatini (53.9%), French Guyana (2.1%), Guatemala (16.9%), Honduras (47.4%), Panama (55.3%), and Sao Tome and Principe (28.9%). (Source: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022/questions-and-answers)

Click any bar or cell to request the full company profile
Company2022 (A)2023 (A)2024 (A)2025 (A)
Sanofi S.A.••• ••• ••• •••
Ipca Laboratories Limited••• ••• ••• •••
Guilin Pharmaceutical Co.••• ••• ••• •••
Ltd.••• ••• ••• •••
KPC Pharmaceuticals••• ••• ••• •••
Inc.••• ••• ••• •••
Cipla Limited••• ••• ••• •••
Ajanta Pharma Limited••• ••• ••• •••
Novartis AG••• ••• ••• •••
Others••• ••• ••• •••

Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.

Request company profile for validation →

Report Scope & Analysis

According to Cognitive Market Research, the global artemisinin market size was USD 65.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 19.50% from 2024 to 2031.

  • North America held the major market share for more than 40% of the global revenue with a market size of USD 26.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.7% from 2024 to 2031.
  • Europe accounted for a market share of over 30% of the global revenue with a market size of USD 19.56 million.
  • Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 15.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.5% from 2024 to 2031.
  • Latin America had a market share of more than 5% of the global revenue with a market size of USD 3.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.9% from 2024 to 2031.
  • Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 1.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.2% from 2024 to 2031.
  • Semisynthetic Artemisinin category is the fastest growing segment of the artemisinin industry

 

Introduction of the Artemisinin Market

Artemisinin is a medicine used to treat malaria caused by Plasmodium in humans. It is a plant extract made from Artemisia annua, sometimes known as sweet wormwood, that has been found to successfully and swiftly reduce the number of Plasmodium parasites in malaria patients' blood. It is produced from the plant and can be produced using yeast, which is more efficient than the plant. Several major drivers drive the artemisinin market, including malaria's high prevalence in places such as Sub-Saharan Africa and Southeast Asia, which produces a continual demand for effective therapies. Furthermore, advances in agricultural practices and increasing investment in research to improve artemisinin yield and extraction procedures help to drive market expansion by boosting supply stability and treatment efficacy.

In April 2024, Novartis released an enhanced formulation of Coartem® Dispersible, which is intended to improve palatability and effectiveness in young children. This updated version includes a more stable dispersible tablet, which simplifies administration and increases dose accuracy. (Source: https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-announce-positive-efficacy-and-safety-data-novel-treatment-babies)

Artemisinin Market Analysis Insights Video

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Artemisinin Market Analysis is witnessing significant growth in the near future.

In 2023, the Extraction from Artemisia Annua segment accounted for a notable share of the Artemisinin Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst · Cognitive Market Research
LinkedIn Profile Book Appointment

Frequently Asked Questions

The global market size for artemisinin in 2024 is USD 65.2 million.
The global artemisinin market is expected to grow with a CAGR of 19.50% over the projected period.
North America held a significant global artemisinin market revenue share in 2024.
Asia-Pacific will witness the fastest growth of the global artemisinin market over the coming years.
The US had the most significant global artemisinin market revenue share in 2024.
The main driver of the growth of the artemisinin market is the growing malaria endemic, as well as new technology advancements.
The semisynthetic artemisinin category dominates the market.

★ Reviews

Rate this report

Artemisinin Market Analysis — Table of Contents

Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
License Edition

Type Extraction from Artemisia Annua, Semisynthetic Artemisinin
Application Antimalarial Injections, Antimalarial Tablets, Others
Distribution Channel Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
List of Competitors Sanofi S.A., Ipca Laboratories Limited, Guilin Pharmaceutical Co., Ltd., KPC Pharmaceuticals, Inc., Cipla Limited, Ajanta Pharma Limited, Novartis AG, Others

  • 1.1 Global Power Realignment & Strategic Alliances
  • 1.2 Geopolitical Risk Landscape & Conflict Hotspots
  • 1.3 International Trade Relations & Market Access Environment
  • 1.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
  • 1.5 Supply Chain Resilience, Localization & Resource Nationalism
  • 1.6 Technology Sovereignty & Digital Geopolitics
  • 1.7 Strategic Implications for Investment, Growth & Market Entry

  • 2.1 Competitive Landscape Disruption & Strategic Shifts
  • 2.2 AI-Driven Transformation of Industry Value Chain
  • 2.3 Evolution of Business Models & Revenue Streams
  • 2.4 Operational Efficiency & Cost Structure Transformation
  • 2.5 Product, Service & Innovation Acceleration
  • 2.6 Customer Behavior & Demand Evolution
  • 2.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

  • 3.1 Global Artemisinin Revenue Market Size, Trend Analysis 2022 - 2034
  • 3.2 Global Artemisinin Volume Market Sales, Trend Analysis 2022 - 2034

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    3.3 Global Artemisinin Market Size By Regions 2022 - 2034
    • 3.3.1 Global Artemisinin Revenue Market Size By Region
    • 3.3.2 Global Artemisinin Volume Market Sales By Region
  • 3.4 Global Artemisinin Market Size By Type 2022 - 2034
    • 3.4.1 Extraction from Artemisia Annua Market Size
    • 3.4.2 Semisynthetic Artemisinin Market Size
  • 3.5 Global Artemisinin Volume Market Sales By Type 2022 - 2034
    • 3.5.1 Extraction from Artemisia Annua Sales Volume
    • 3.5.2 Semisynthetic Artemisinin Sales Volume
  • 3.6 Global Artemisinin Market Size By Application 2022 - 2034
    • 3.6.1 Antimalarial Injections Market Size
    • 3.6.2 Antimalarial Tablets Market Size
    • 3.6.3 Others Market Size
  • 3.7 Global Artemisinin Volume Market Sales By Application 2022 - 2034
    • 3.7.1 Antimalarial Injections Sales Volume
    • 3.7.2 Antimalarial Tablets Sales Volume
    • 3.7.3 Others Sales Volume
  • 3.8 Global Artemisinin Market Size By Distribution Channel 2022 - 2034
    • 3.8.1 Hospital Pharmacy Market Size
    • 3.8.2 Retail Pharmacy Market Size
    • 3.8.3 Online Pharmacy Market Size
    • 3.8.4 Others Market Size
  • 3.9 Global Artemisinin Volume Market Sales By Distribution Channel 2022 - 2034
    • 3.9.1 Hospital Pharmacy Sales Volume
    • 3.9.2 Retail Pharmacy Sales Volume
    • 3.9.3 Online Pharmacy Sales Volume
    • 3.9.4 Others Sales Volume
  • 3.10 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    3.11 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 3.11.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 3.11.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
    • 3.11.3 Global Market Revenue Split By Type
    • 3.11.4 Global Volume Market Split By Type
    • 3.11.5 Global Market Revenue Split By Application
    • 3.11.6 Global Volume Market Split By Application
    • 3.11.7 Global Market Revenue Split By Distribution Channel
    • 3.11.8 Global Volume Market Split By Distribution Channel

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      3.11.9 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

  • 4.1 North America Artemisinin Market Outlook
    • 4.1.1 North America Artemisinin Market Size 2022 - 2034
    • 4.1.2 North America Artemisinin Volume Market Sales 2022 - 2034
    • 4.1.3 North America Artemisinin Market Size By Country 2022 - 2034
    • 4.1.4 North America Artemisinin Volume Market Sales By Country 2022 - 2034
    • 4.1.5 North America Artemisinin Market Size by Type 2022 - 2034
      • 4.1.5.1 North America Extraction from Artemisia Annua Market Size
      • 4.1.5.2 North America Semisynthetic Artemisinin Market Size
    • 4.1.6 North America Artemisinin Volume Market Sales by Type 2022 - 2034
      • 4.1.6.1 North America Extraction from Artemisia Annua Sales Volume
      • 4.1.6.2 North America Semisynthetic Artemisinin Sales Volume
    • 4.1.7 North America Artemisinin Market Size by Application 2022 - 2034
      • 4.1.7.1 North America Antimalarial Injections Market Size
      • 4.1.7.2 North America Antimalarial Tablets Market Size
      • 4.1.7.3 North America Others Market Size
    • 4.1.8 North America Artemisinin Volume Market Sales by Application 2022 - 2034
      • 4.1.8.1 North America Antimalarial Injections Sales Volume
      • 4.1.8.2 North America Antimalarial Tablets Sales Volume
      • 4.1.8.3 North America Others Sales Volume
    • 4.1.9 North America Artemisinin Market Size by Distribution Channel 2022 - 2034
      • 4.1.9.1 North America Hospital Pharmacy Market Size
      • 4.1.9.2 North America Retail Pharmacy Market Size
      • 4.1.9.3 North America Online Pharmacy Market Size
      • 4.1.9.4 North America Others Market Size
    • 4.1.10 North America Artemisinin Volume Market Sales by Distribution Channel 2022 - 2034
      • 4.1.10.1 North America Hospital Pharmacy Sales Volume
      • 4.1.10.2 North America Retail Pharmacy Sales Volume
      • 4.1.10.3 North America Online Pharmacy Sales Volume
      • 4.1.10.4 North America Others Sales Volume

  • 5.1 Europe Artemisinin Market Outlook
    • 5.1.1 Europe Artemisinin Market Size 2022 - 2034
    • 5.1.2 Europe Artemisinin Volume Market Sales 2022 - 2034
    • 5.1.3 Europe Artemisinin Market Size By Country 2022 - 2034
    • 5.1.4 Europe Artemisinin Volume Market Sales By Country 2022 - 2034
    • 5.1.5 Europe Artemisinin Market Size by Type 2022 - 2034
      • 5.1.5.1 Europe Extraction from Artemisia Annua Market Size
      • 5.1.5.2 Europe Semisynthetic Artemisinin Market Size
    • 5.1.6 Europe Artemisinin Volume Market Sales by Type 2022 - 2034
      • 5.1.6.1 Europe Extraction from Artemisia Annua Sales Volume
      • 5.1.6.2 Europe Semisynthetic Artemisinin Sales Volume
    • 5.1.7 Europe Artemisinin Market Size by Application 2022 - 2034
      • 5.1.7.1 Europe Antimalarial Injections Market Size
      • 5.1.7.2 Europe Antimalarial Tablets Market Size
      • 5.1.7.3 Europe Others Market Size
    • 5.1.8 Europe Artemisinin Volume Market Sales by Application 2022 - 2034
      • 5.1.8.1 Europe Antimalarial Injections Sales Volume
      • 5.1.8.2 Europe Antimalarial Tablets Sales Volume
      • 5.1.8.3 Europe Others Sales Volume
    • 5.1.9 Europe Artemisinin Market Size by Distribution Channel 2022 - 2034
      • 5.1.9.1 Europe Hospital Pharmacy Market Size
      • 5.1.9.2 Europe Retail Pharmacy Market Size
      • 5.1.9.3 Europe Online Pharmacy Market Size
      • 5.1.9.4 Europe Others Market Size
    • 5.1.10 Europe Artemisinin Volume Market Sales by Distribution Channel 2022 - 2034
      • 5.1.10.1 Europe Hospital Pharmacy Sales Volume
      • 5.1.10.2 Europe Retail Pharmacy Sales Volume
      • 5.1.10.3 Europe Online Pharmacy Sales Volume
      • 5.1.10.4 Europe Others Sales Volume

  • 6.1 Asia Pacific Artemisinin Market Outlook
    • 6.1.1 Asia Pacific Artemisinin Market Size 2022 - 2034
    • 6.1.2 Asia Pacific Artemisinin Volume Market Sales 2022 - 2034
    • 6.1.3 Asia Pacific Artemisinin Market Size By Country 2022 - 2034
    • 6.1.4 Asia Pacific Artemisinin Volume Market Sales By Country 2022 - 2034
    • 6.1.5 Asia Pacific Artemisinin Market Size by Type 2022 - 2034
      • 6.1.5.1 Asia Pacific Extraction from Artemisia Annua Market Size
      • 6.1.5.2 Asia Pacific Semisynthetic Artemisinin Market Size
    • 6.1.6 Asia Pacific Artemisinin Volume Market Sales by Type 2022 - 2034
      • 6.1.6.1 Asia Pacific Extraction from Artemisia Annua Sales Volume
      • 6.1.6.2 Asia Pacific Semisynthetic Artemisinin Sales Volume
    • 6.1.7 Asia Pacific Artemisinin Market Size by Application 2022 - 2034
      • 6.1.7.1 Asia Pacific Antimalarial Injections Market Size
      • 6.1.7.2 Asia Pacific Antimalarial Tablets Market Size
      • 6.1.7.3 Asia Pacific Others Market Size
    • 6.1.8 Asia Pacific Artemisinin Volume Market Sales by Application 2022 - 2034
      • 6.1.8.1 Asia Pacific Antimalarial Injections Sales Volume
      • 6.1.8.2 Asia Pacific Antimalarial Tablets Sales Volume
      • 6.1.8.3 Asia Pacific Others Sales Volume
    • 6.1.9 Asia Pacific Artemisinin Market Size by Distribution Channel 2022 - 2034
      • 6.1.9.1 Asia Pacific Hospital Pharmacy Market Size
      • 6.1.9.2 Asia Pacific Retail Pharmacy Market Size
      • 6.1.9.3 Asia Pacific Online Pharmacy Market Size
      • 6.1.9.4 Asia Pacific Others Market Size
    • 6.1.10 Asia Pacific Artemisinin Volume Market Sales by Distribution Channel 2022 - 2034
      • 6.1.10.1 Asia Pacific Hospital Pharmacy Sales Volume
      • 6.1.10.2 Asia Pacific Retail Pharmacy Sales Volume
      • 6.1.10.3 Asia Pacific Online Pharmacy Sales Volume
      • 6.1.10.4 Asia Pacific Others Sales Volume

  • 7.1 South America Artemisinin Market Outlook
    • 7.1.1 South America Artemisinin Market Size 2022 - 2034
    • 7.1.2 South America Artemisinin Volume Market Sales 2022 - 2034
    • 7.1.3 South America Artemisinin Market Size By Country 2022 - 2034
    • 7.1.4 South America Artemisinin Volume Market Sales By Country 2022 - 2034
    • 7.1.5 South America Artemisinin Market Size by Type 2022 - 2034
      • 7.1.5.1 South America Extraction from Artemisia Annua Market Size
      • 7.1.5.2 South America Semisynthetic Artemisinin Market Size
    • 7.1.6 South America Artemisinin Volume Market Sales by Type 2022 - 2034
      • 7.1.6.1 South America Extraction from Artemisia Annua Sales Volume
      • 7.1.6.2 South America Semisynthetic Artemisinin Sales Volume
    • 7.1.7 South America Artemisinin Market Size by Application 2022 - 2034
      • 7.1.7.1 South America Antimalarial Injections Market Size
      • 7.1.7.2 South America Antimalarial Tablets Market Size
      • 7.1.7.3 South America Others Market Size
    • 7.1.8 South America Artemisinin Volume Market Sales by Application 2022 - 2034
      • 7.1.8.1 South America Antimalarial Injections Sales Volume
      • 7.1.8.2 South America Antimalarial Tablets Sales Volume
      • 7.1.8.3 South America Others Sales Volume
    • 7.1.9 South America Artemisinin Market Size by Distribution Channel 2022 - 2034
      • 7.1.9.1 South America Hospital Pharmacy Market Size
      • 7.1.9.2 South America Retail Pharmacy Market Size
      • 7.1.9.3 South America Online Pharmacy Market Size
      • 7.1.9.4 South America Others Market Size
    • 7.1.10 South America Artemisinin Volume Market Sales by Distribution Channel 2022 - 2034
      • 7.1.10.1 South America Hospital Pharmacy Sales Volume
      • 7.1.10.2 South America Retail Pharmacy Sales Volume
      • 7.1.10.3 South America Online Pharmacy Sales Volume
      • 7.1.10.4 South America Others Sales Volume

  • 8.1 Middle East Artemisinin Market Outlook
    • 8.1.1 Middle East Artemisinin Market Size 2022 - 2034
    • 8.1.2 Middle East Artemisinin Volume Market Sales 2022 - 2034
    • 8.1.3 Middle East Artemisinin Market Size By Country 2022 - 2034
    • 8.1.4 Middle East Artemisinin Volume Market Sales By Country 2022 - 2034
    • 8.1.5 Middle East Artemisinin Market Size by Type 2022 - 2034
      • 8.1.5.1 Middle East Extraction from Artemisia Annua Market Size
      • 8.1.5.2 Middle East Semisynthetic Artemisinin Market Size
    • 8.1.6 Middle East Artemisinin Volume Market Sales by Type 2022 - 2034
      • 8.1.6.1 Middle East Extraction from Artemisia Annua Sales Volume
      • 8.1.6.2 Middle East Semisynthetic Artemisinin Sales Volume
    • 8.1.7 Middle East Artemisinin Market Size by Application 2022 - 2034
      • 8.1.7.1 Middle East Antimalarial Injections Market Size
      • 8.1.7.2 Middle East Antimalarial Tablets Market Size
      • 8.1.7.3 Middle East Others Market Size
    • 8.1.8 Middle East Artemisinin Volume Market Sales by Application 2022 - 2034
      • 8.1.8.1 Middle East Antimalarial Injections Sales Volume
      • 8.1.8.2 Middle East Antimalarial Tablets Sales Volume
      • 8.1.8.3 Middle East Others Sales Volume
    • 8.1.9 Middle East Artemisinin Market Size by Distribution Channel 2022 - 2034
      • 8.1.9.1 Middle East Hospital Pharmacy Market Size
      • 8.1.9.2 Middle East Retail Pharmacy Market Size
      • 8.1.9.3 Middle East Online Pharmacy Market Size
      • 8.1.9.4 Middle East Others Market Size
    • 8.1.10 Middle East Artemisinin Volume Market Sales by Distribution Channel 2022 - 2034
      • 8.1.10.1 Middle East Hospital Pharmacy Sales Volume
      • 8.1.10.2 Middle East Retail Pharmacy Sales Volume
      • 8.1.10.3 Middle East Online Pharmacy Sales Volume
      • 8.1.10.4 Middle East Others Sales Volume

  • 9.1 Africa Artemisinin Market Outlook
    • 9.1.1 Africa Artemisinin Market Size 2022 - 2034
    • 9.1.2 Africa Artemisinin Volume Market Sales 2022 - 2034
    • 9.1.3 Africa Artemisinin Market Size By Country 2022 - 2034
    • 9.1.4 Africa Artemisinin Volume Market Sales By Country 2022 - 2034
    • 9.1.5 Africa Artemisinin Market Size by Type 2022 - 2034
      • 9.1.5.1 Africa Extraction from Artemisia Annua Market Size
      • 9.1.5.2 Africa Semisynthetic Artemisinin Market Size
    • 9.1.6 Africa Artemisinin Volume Market Sales by Type 2022 - 2034
      • 9.1.6.1 Africa Extraction from Artemisia Annua Sales Volume
      • 9.1.6.2 Africa Semisynthetic Artemisinin Sales Volume
    • 9.1.7 Africa Artemisinin Market Size by Application 2022 - 2034
      • 9.1.7.1 Africa Antimalarial Injections Market Size
      • 9.1.7.2 Africa Antimalarial Tablets Market Size
      • 9.1.7.3 Africa Others Market Size
    • 9.1.8 Africa Artemisinin Volume Market Sales by Application 2022 - 2034
      • 9.1.8.1 Africa Antimalarial Injections Sales Volume
      • 9.1.8.2 Africa Antimalarial Tablets Sales Volume
      • 9.1.8.3 Africa Others Sales Volume
    • 9.1.9 Africa Artemisinin Market Size by Distribution Channel 2022 - 2034
      • 9.1.9.1 Africa Hospital Pharmacy Market Size
      • 9.1.9.2 Africa Retail Pharmacy Market Size
      • 9.1.9.3 Africa Online Pharmacy Market Size
      • 9.1.9.4 Africa Others Market Size
    • 9.1.10 Africa Artemisinin Volume Market Sales by Distribution Channel 2022 - 2034
      • 9.1.10.1 Africa Hospital Pharmacy Sales Volume
      • 9.1.10.2 Africa Retail Pharmacy Sales Volume
      • 9.1.10.3 Africa Online Pharmacy Sales Volume
      • 9.1.10.4 Africa Others Sales Volume

  • 10.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      10.1.1 Global Artemisinin Market Revenue and Share by Key Players
    • 10.1.2 Global Artemisinin Market Volume and Share by Key Players
    • 10.1.3 Top Players Ranking 2024
    • 10.1.4 New Product Launch Analysis
    • 10.1.5 Industry Mergers and Acquisition Analysis
  • 10.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.1 Sanofi S.A.
      • 10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.1.2 Business Overview
      • 10.2.1.3 Financials (Subject to data availability)
      • 10.2.1.4 R&D Investment (Subject to data availability)
      • 10.2.1.5 Product Types Specification
      • 10.2.1.6 Business Strategy
      • 10.2.1.7 Recent Developments
      • 10.2.1.8 Management Change
      • 10.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.2 Ipca Laboratories Limited
      • 10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.2.2 Business Overview
      • 10.2.2.3 Financials (Subject to data availability)
      • 10.2.2.4 R&D Investment (Subject to data availability)
      • 10.2.2.5 Product Types Specification
      • 10.2.2.6 Business Strategy
      • 10.2.2.7 Recent Developments
      • 10.2.2.8 Management Change
      • 10.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.3 Guilin Pharmaceutical Co.
      • 10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.3.2 Business Overview
      • 10.2.3.3 Financials (Subject to data availability)
      • 10.2.3.4 R&D Investment (Subject to data availability)
      • 10.2.3.5 Product Types Specification
      • 10.2.3.6 Business Strategy
      • 10.2.3.7 Recent Developments
      • 10.2.3.8 Management Change
      • 10.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.4 Ltd.
      • 10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.4.2 Business Overview
      • 10.2.4.3 Financials (Subject to data availability)
      • 10.2.4.4 R&D Investment (Subject to data availability)
      • 10.2.4.5 Product Types Specification
      • 10.2.4.6 Business Strategy
      • 10.2.4.7 Recent Developments
      • 10.2.4.8 Management Change
      • 10.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.5 KPC Pharmaceuticals
      • 10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.5.2 Business Overview
      • 10.2.5.3 Financials (Subject to data availability)
      • 10.2.5.4 R&D Investment (Subject to data availability)
      • 10.2.5.5 Product Types Specification
      • 10.2.5.6 Business Strategy
      • 10.2.5.7 Recent Developments
      • 10.2.5.8 Management Change
      • 10.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.6 Inc.
      • 10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.6.2 Business Overview
      • 10.2.6.3 Financials (Subject to data availability)
      • 10.2.6.4 R&D Investment (Subject to data availability)
      • 10.2.6.5 Product Types Specification
      • 10.2.6.6 Business Strategy
      • 10.2.6.7 Recent Developments
      • 10.2.6.8 Management Change
      • 10.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.7 Cipla Limited
      • 10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.7.2 Business Overview
      • 10.2.7.3 Financials (Subject to data availability)
      • 10.2.7.4 R&D Investment (Subject to data availability)
      • 10.2.7.5 Product Types Specification
      • 10.2.7.6 Business Strategy
      • 10.2.7.7 Recent Developments
      • 10.2.7.8 Management Change
      • 10.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.8 Ajanta Pharma Limited
      • 10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.8.2 Business Overview
      • 10.2.8.3 Financials (Subject to data availability)
      • 10.2.8.4 R&D Investment (Subject to data availability)
      • 10.2.8.5 Product Types Specification
      • 10.2.8.6 Business Strategy
      • 10.2.8.7 Recent Developments
      • 10.2.8.8 Management Change
      • 10.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.9 Novartis AG
      • 10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.9.2 Business Overview
      • 10.2.9.3 Financials (Subject to data availability)
      • 10.2.9.4 R&D Investment (Subject to data availability)
      • 10.2.9.5 Product Types Specification
      • 10.2.9.6 Business Strategy
      • 10.2.9.7 Recent Developments
      • 10.2.9.8 Management Change
      • 10.2.9.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.10 Others
      • 10.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.10.2 Business Overview
      • 10.2.10.3 Financials (Subject to data availability)
      • 10.2.10.4 R&D Investment (Subject to data availability)
      • 10.2.10.5 Product Types Specification
      • 10.2.10.6 Business Strategy
      • 10.2.10.7 Recent Developments
      • 10.2.10.8 Management Change
      • 10.2.10.9 S.W.O.T Analysis

  • 11.1 Market Drivers
  • 11.2 Market Restraints
  • 11.3 Market Trends
  • 11.4 Market Opportunity
  • 11.5 Technological Road Map (Subject to Data Availability)
  • 11.6 Product Life Cycle (Subject to Data Availability)
  • 11.7 Customer and Buyer Behavior Analysis
    • 11.7.1 Consumer Demographics and Target Audience Assessment
    • 11.7.2 Consumer Purchase Behavior and Demand Assessment
    • 11.7.3 Consumer Pricing Dynamics and Affordability Assessment
    • 11.7.4 Digital Consumer Engagement and Online Adoption Analysis
    • 11.7.5 Future Consumption Trends and Demand Evolution Analysis
    • 11.7.6 Enterprise Procurement & Purchasing Behavior Analysis
    • 11.7.7 Buyer Decision-Making & Purchase Influence Assessment
    • 11.7.8 Customer Expectations & Service Experience Evaluation
    • 11.7.9 Vendor Selection & Supplier Preference Analysis
    • 11.7.10 Customer Retention & Loyalty Strategy Assessment
    • 11.7.11 Pricing Sensitivity & Value Perception Analysis
    • 11.7.12 Customer Segmentation & Demand Pattern Analysis
    • 11.7.13 Relationship Management & Strategic Partnership Trends
  • 11.8 Market Attractiveness Analysis
  • 11.9 PESTEL Analysis
    • 11.9.1 Political Factors
    • 11.9.2 Economic Factors
    • 11.9.3 Social Factors
    • 11.9.4 Technological Factors
    • 11.9.5 Legal Factors
    • 11.9.6 Environmental Factors
  • 11.10 Industrial Chain Analysis (Subject to Data Availability)
    • 11.10.1 Industry Chain Analysis
    • 11.10.2 Manufacturing Cost Analysis
    • 11.10.3 Supply Side Analysis
      • 11.10.3.1 Raw Material Analysis
      • 11.10.3.2 Raw Material Procurement Analysis
      • 11.10.3.3 Raw Material Price Trend Analysis
  • 11.11 Porter’s Five Forces Analysis
    • 11.11.1 Bargaining Power of Suppliers
    • 11.11.2 Bargaining Power of Buyers
    • 11.11.3 Threat of New Entrants
    • 11.11.4 Threat of Substitutes
    • 11.11.5 Degree of Competition
  • 11.12 Patent Analysis (Subject to Data Availability)
  • 11.13 ESG Analysis

  • 12.1 Extraction from Artemisia Annua
    • 12.1.1 Global Artemisinin Revenue Market Size and Share by Extraction from Artemisia Annua 2022 - 2034
    • 12.1.2 Global Artemisinin Volume Market Sales by Extraction from Artemisia Annua 2022 - 2034
  • 12.2 Semisynthetic Artemisinin
    • 12.2.1 Global Artemisinin Revenue Market Size and Share by Semisynthetic Artemisinin 2022 - 2034
    • 12.2.2 Global Artemisinin Volume Market Sales by Semisynthetic Artemisinin 2022 - 2034

  • 13.1 Antimalarial Injections
    • 13.1.1 Global Artemisinin Revenue Market Size and Share by Antimalarial Injections 2022 - 2034
    • 13.1.2 Global Artemisinin Volume Market Sales by Antimalarial Injections 2022 - 2034
  • 13.2 Antimalarial Tablets
    • 13.2.1 Global Artemisinin Revenue Market Size and Share by Antimalarial Tablets 2022 - 2034
    • 13.2.2 Global Artemisinin Volume Market Sales by Antimalarial Tablets 2022 - 2034
  • 13.3 Others
    • 13.3.1 Global Artemisinin Revenue Market Size and Share by Others 2022 - 2034
    • 13.3.2 Global Artemisinin Volume Market Sales by Others 2022 - 2034

  • 14.1 Hospital Pharmacy
    • 14.1.1 Global Artemisinin Revenue Market Size and Share by Hospital Pharmacy 2022 - 2034
    • 14.1.2 Global Artemisinin Volume Market Sales by Hospital Pharmacy 2022 - 2034
  • 14.2 Retail Pharmacy
    • 14.2.1 Global Artemisinin Revenue Market Size and Share by Retail Pharmacy 2022 - 2034
    • 14.2.2 Global Artemisinin Volume Market Sales by Retail Pharmacy 2022 - 2034
  • 14.3 Online Pharmacy
    • 14.3.1 Global Artemisinin Revenue Market Size and Share by Online Pharmacy 2022 - 2034
    • 14.3.2 Global Artemisinin Volume Market Sales by Online Pharmacy 2022 - 2034
  • 14.4 Others
    • 14.4.1 Global Artemisinin Revenue Market Size and Share by Others 2022 - 2034
    • 14.4.2 Global Artemisinin Volume Market Sales by Others 2022 - 2034

  • 15.1 Company Gap Assessment Analysis
  • 15.2 Product & Service Portfolio Gap Analysis
  • 15.3 Demand-Supply Imbalance Analysis
  • 15.4 Market Opportunity & Unmet Needs Analysis
  • 15.5 Technology Adoption & Digital Transformation Gap Analysis
  • 15.6 Operational Efficiency & Process Gap Analysis
  • 15.7 Infrastructure & Capacity Gap Analysis
  • 15.8 Geographic Coverage & Distribution Gap Analysis
  • 15.9 Investment Opportunity & Funding Gap Analysis
  • 15.10 Pricing Structure & Margin Gap Analysis
  • 15.11 Innovation & R&D Capability Gap Analysis
  • 15.12 Policy, Compliance & Regulatory Gap Analysis
  • 15.13 Customer Experience & Expectation Gap Analysis
  • 15.14 Future Growth Opportunity Gap Analysis
  • 15.15 Market Accessibility & Penetration Gap Analysis

  • 16.1 Gross Margin Overview and Industry Profitability Trends
  • 16.2 Regional Gross Margin Performance Analysis
  • 16.3 Supply Chain and Distribution Impact on Gross Margins
  • 16.4 Pricing Strategy and Value-Added Margin Assessment
  • 16.5 Key Factors Influencing Gross Margin Variability
  • 16.6 Future Gross Margin Outlook and Profitability Trends

  • 17.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    17.2 Analyst Point of View
  • 17.3 Assumptions and Acronyms

  • 18.1 Primary Data Collection
    • 18.1.1 Steps for Primary Data Collection
      • 18.1.1.1 Identification of KOL
    • 18.1.2 Backward Integration
    • 18.1.3 Forward Integration
    • 18.1.4 How Primary Research Help Us
    • 18.1.5 Modes of Primary Research
  • 18.2 Secondary Research
    • 18.2.1 How Secondary Research Help Us
    • 18.2.2 Sources of Secondary Research
  • 18.3 Data Validation
    • 18.3.1 Data Triangulation
    • 18.3.2 Top Down & Bottom Up Approach
    • 18.3.3 Cross check KOL Responses with Secondary Data
  • 18.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Artemisinin Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 10+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about Artemisinin Market

Sources from Pharma & Healthcare Industry

How We Serve You

Three Pillars of Market Intelligence

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Artemisinin Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the artemisinin market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.